| AGD | agar gel diffusion; agarose diffusion; alpha-ketoglutarate dehydrogenase |
|---|---|
| DP | data processing; deep pulse; definitive procedure; degradation product; degree of polymerization; de... |
| ADT | Accepted Dental Therapeutics; adenosine triphosphate; admission, discharge, transfer; agar-gel diffu... |
| AGDD | agar gel double diffusion |
| BCYE-α agar | Buffered Charcoal Yeast Extract agar with α-ketoglutarate |
| AGD | agar gel diffusion |
|---|---|
| AGID | Agar Gel Immunodiffusion |
| AGP | Agar Gel Precipitin |
| MHA | Mueller Hinton agar |
| PDA | Potato Dextrose Agar |
| ambipolar diffusion | <radiobiology> Diffusion process in which buildup of spatial charge creates electric fields which cause electrons and ions to leave the plasma at the same rate. (Such electric fields are self-generated by the plasma and act to preserve charge neutrality.) (09 Oct 1997) |
|---|---|
| anomalous diffusion | <radiobiology> Diffusion in most plasma devices, particularly tokamaks, is higher than what one would predict from understood causes. The observed, typical diffusion is referred to as anomalous because it has not yet been explained. Anomalous diffusion includes all diffusion which is not due to collisions and geometric effects. While such effects were not understood when the term was coined, and most still are not, diffusion due to well-understood wave phenomena is still 'anomalous'. Classical diffusion and Neo-classical diffusion are the two well-understood diffusion theories, although neither is adequate to fully explain the observed anomalous diffusion. See: entries for classical diffusion and neoclassical diffusion. Anomalous resistivity (09 Oct 1997) |
| bohm diffusion | <radiobiology> A rapid loss of plasma across magnetic field lines caused by microinstabilities. Theory formulated by the physicist David Bohm. Semiempirical formula for the diffusion coefficient given by Bohm in 1946 (noted by Bohm, Burhop, and Massey, who were developing a magnetic arc for use in uranium isotope separation). Bohm diffusion was proposed (not derived from first principles) to scale as 1/B rather than the 1/B^2 scaling predicted by classical diffusion. A 1/B scaling results from assuming that particles diffuse across field lines at an optimum rate (effective collision frequency=cyclotron frequency). The 1/B scaling is observed (approximately) in most reactors. See: diffusion, microinstabilities, field lines. (09 Oct 1997) |
| gel diffusion | Diffusion in a gel, as in the case of gel diffusion precipitin tests in which the immune reactants diffuse in agar. See: immunodiffusion. (05 Mar 2000) |
| gel diffusion precipitin tests | Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions. Synonym: gel diffusion reactions. (05 Mar 2000) |
| gel diffusion precipitin tests in one dimension | Precipitin test's in which antigen solution and antibody incorporated in agar are layered in tubes, permitting effective diffusion in the vertical dimension; the antibody-containing agar may be overlaid directly with antigen solution (single (gel) diffusion in one dimension). (05 Mar 2000) |
| gel diffusion precipitin tests in two dimensions | Precipitin test's made in a layer of agar that permits radial diffusion, in both of the horizontal dimensions, of one or both reactants. Double (gel) diffusion in two dimensions (Ouchterlony test, technique, or method) incorporates antigen and antibody solutions placed in separate wells in a sheet of plain agar, permitting radial diffusion of both reactants; this method is widely used to determine antigenic relationships; the bands of precipitate that form where the reactants meet in optimal concentration are of three patterns, referred to as reaction of identity, reaction of partial identity (cross-reaction), and reaction of nonidentity. (05 Mar 2000) |
| gel diffusion reactions | Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions. Synonym: gel diffusion reactions. (05 Mar 2000) |
| passive diffusion | See: facilitated transport. (05 Mar 2000) |
| classical diffusion | <radiobiology> In plasma physics, diffusion due solely to scattering (collisions) of charged particles (with unlike charges) via electrical (Coulomb) interactions. (See also diffusion.) (09 Oct 1997) |
| population diffusion coefficient | <cell biology> Coefficient that describes the tendency of a population of motile cells to diffuse through the environment. Its use presupposes that the cells move in a random walk. (18 Nov 1997) |
| neoclassical diffusion | <radiobiology> In a magnetised plasma, _classical_ diffusion refers to transport of particles due to Coulomb collisions, taking the spiral orbits in the magnetic field into account. In a toroidal magnetic field, the actual rate of diffusive transport is much higher due to slow changes in the positions of the centres of the spirals, known as banana orbits. This faster transport is called _neo-classical_. With very few exceptions the transport in toroidal devices is observed to be 10-100 times larger still, presumably due to small-scale turbulence. The observed transport is called _anomalous_ (although it actually is the normal state). (09 Oct 1997) |
| diffusion | The process of becoming diffused or widely spread, the spontaneous movement of molecules or other particles in solution, owing to their random thermal motion, to reach a uniform concentration throughout the solvent, a process requiring no addition of energy to the system. (18 Nov 1997) |
| diffusion anoxia | Diffusion hypoxia severe enough to result in the absence of oxygen in alveolar gas. (05 Mar 2000) |
| diffusion chambers, culture | Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|